8 Invasive Candidiasis Symptoms of a Systemic Yeast Infection

Most people are familiar with localized yeast infections, such as oral thrush or standard vaginal infections, which are easily resolved with over-the-counter creams. However, when the Candida fungus escapes these localized barriers and breaches the bloodstream, it mutates into a silent and profoundly dangerous medical emergency known as invasive candidiasis. Far from a simple case of yeast overgrowth, this systemic fungal infection can rapidly migrate to your vital organs, taking root in the heart, brain, kidneys, eyes, and bones.

The scope and severity of this condition are staggering. According to surveillance data from the Centers for Disease Control and Prevention (CDC), invasive candidiasis is one of the most common healthcare-associated bloodstream infections in the United States, driving an estimated 46,000 cases each year. This is not a benign condition that your immune system can casually fight off.

Despite the administration of powerful modern intravenous antifungal therapies, systemic Candida bloodstream infections carry a devastating 30% to 40% all-cause mortality rate. It is particularly aggressive among medically vulnerable individuals such as those with diabetes, patients recovering in intensive care units (ICUs), or anyone with an indwelling central line catheter. Furthermore, the threat is compounding as emerging, multi-drug resistant strains like Candida auris continue to spread across healthcare facilities globally, rendering standard treatments entirely ineffective in up to 60% of cases.

The true danger of invasive candidiasis lies in its ambiguity. Because it lacks a single, definitive “signature” physical trait, its onset is frequently masked by the symptoms of the patient’s existing illness, leading to dangerous delays in diagnosis.

Read on to explore the 8 critical symptoms of a systemic yeast infection, learn how doctors distinguish this dangerous fungal invader from routine bacterial sepsis, and understand the immediate medical treatments required to stop it in its tracks.

8 Key Symptoms of Invasive Candidiasis

Unexplained Fevers and Chills

Unexplained fevers and chills are frequently the earliest and most common symptoms of invasive candidiasis, often presenting as the initial sign that a serious systemic infection is underway. This symptom arises as the body’s innate immune system recognizes the presence of Candida yeast in the bloodstream and initiates a powerful inflammatory response.

The immune system releases pyrogenic cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), which travel to the hypothalamus in the brain, the body’s thermostat. These chemical messengers reset the body’s core temperature setpoint to a higher level, triggering a fever. The accompanying chills and shivering are the body’s physiological mechanisms to generate heat and raise its temperature to this new, higher setpoint.

A critical diagnostic clue that points toward a fungal rather than a bacterial cause is the persistence of these fevers despite the administration of broad-spectrum antibiotic therapy. In a clinical setting, particularly in hospitalized or critically ill patients, a fever that does not resolve after several days of powerful antibiotics should raise a high index of suspicion for a non-bacterial pathogen, with invasive candidiasis being a primary consideration. This resistance to antibacterial agents occurs because antibiotics are designed to target bacteria and have no effect on fungi like Candida.

The infection continues to proliferate unchecked, perpetuating the systemic inflammatory response and the associated fever. Therefore, a fever of unknown origin in a high-risk patient is a major red flag that prompts clinicians to consider and test for a fungal etiology, often leading to the initiation of empirical antifungal treatment while awaiting definitive diagnostic results.

Persistent Fatigue and a Feeling of Sickness (Malaise)

Persistent fatigue and a general feeling of profound sickness, known as malaise, are hallmark symptoms of the systemic burden caused by invasive candidiasis. This is not the ordinary tiredness experienced after a long day or poor night’s sleep; rather, it is a debilitating, all-encompassing exhaustion that significantly impairs a person’s ability to perform even basic daily activities.

This profound fatigue stems directly from the body’s massive and sustained effort to combat a widespread infection. The immune system mounts a full-scale war against the invading Candida fungus, a process that consumes vast amounts of energy and metabolic resources. The continuous production of inflammatory cytokines, activation of immune cells, and repair of damaged tissues create a state of physiological stress that manifests as extreme physical and mental exhaustion.

Malaise, the accompanying sense of being generally unwell, is also driven by this systemic inflammatory response. The same cytokines that cause fever and chills also impact the central nervous system and other bodily systems, leading to symptoms like loss of appetite, lethargy, and a lack of interest in one’s surroundings. This feeling of sickness is a protective mechanism, signaling the body to rest and conserve energy to dedicate all available resources to fighting the infection.

In the context of invasive candidiasis, this fatigue and malaise are relentless and progressive, often worsening as the infection spreads. It is a clear indicator that the body is under severe duress from a deep-seated, systemic disease process, distinguishing it from the localized discomfort of a superficial yeast infection. For patients, this symptom can be deeply distressing, contributing to a significant decline in their quality of life and overall well-being during the illness.

Low Blood Pressure (Hypotension)

Low blood pressure, or hypotension, is a grave and life-threatening symptom of invasive candidiasis that signifies the progression of the infection to a state of septic shock. When Candida proliferates in the bloodstream, it releases toxins and cell wall components (like beta-glucans) that trigger an overwhelming and dysregulated systemic inflammatory response.

This cascade, similar to that seen in bacterial sepsis, causes widespread vasodilation, where blood vessels throughout the body relax and dramatically expand in diameter. This expansion significantly increases the volume of the circulatory system without a corresponding increase in blood volume, leading to a precipitous drop in blood pressure. Concurrently, the inflammation can make the capillaries “leaky,” allowing fluid to shift from the bloodstream into surrounding tissues, further depleting the volume of circulating blood and exacerbating the hypotension.

This dangerously low blood pressure severely compromises the body’s ability to deliver oxygen-rich blood to vital organs like the brain, heart, and kidneys. When organs are deprived of adequate blood flow (a state known as hypoperfusion), they begin to malfunction and can ultimately fail, which is the hallmark of septic shock and multiple organ dysfunction syndrome (MODS).

Symptoms of this critical state include dizziness, lightheadedness, fainting, cold and clammy skin, rapid and shallow breathing, and a weak, thready pulse. The development of hypotension in a patient with suspected invasive candidiasis is a medical emergency requiring immediate intervention in an intensive care setting.

Treatment involves aggressive fluid resuscitation to increase blood volume and the use of vasopressor medications to constrict blood vessels and raise blood pressure, alongside urgent administration of potent intravenous antifungal therapy to control the underlying infection. The onset of hypotension is a critical turning point that dramatically increases the mortality risk associated with invasive candidiasis.

Skin Rashes or Pustules

The appearance of specific skin rashes or pustules can be a highly revealing symptom of invasive candidiasis, providing a visible clue that the fungal infection has disseminated through the bloodstream. When Candida yeast travels via the circulatory system, it can seed various organs, including the skin. This hematogenous spread leads to characteristic cutaneous manifestations that can aid in diagnosis.

These skin lesions typically appear as multiple, non-blanching erythematous (red or purplish) macules or papules, which are small, flat or slightly raised spots. In many cases, these can progress into pustules (small, pus-filled blisters) or tender nodules that may have a necrotic or hemorrhagic center. The lesions can appear anywhere on the body but are often found on the trunk and extremities.

The presence of these skin lesions is clinically significant because they offer a direct and accessible site for diagnosis. A healthcare provider can perform a skin biopsy, where a small sample of the affected tissue is removed and sent to a laboratory.

Under a microscope, pathologists can identify the yeast forms of Candida within the tissue, and the sample can also be cultured to grow the fungus and confirm the species. This provides a definitive diagnosis of disseminated candidiasis, which can sometimes be difficult to confirm through blood cultures alone, as they can be negative in up to 50% of cases of deep-seated infection.

The rash associated with systemic candidiasis is distinct from common, localized fungal skin infections (like athlete’s foot or ringworm) because it reflects a serious internal disease process rather than a superficial one. The sudden eruption of these specific pustules or nodules in a high-risk, critically ill patient is a strong indicator of candidemia and warrants immediate investigation and treatment.

Muscle Acheness (Myalgia)

Deep and persistent muscle acheness, known as myalgia, is another significant symptom indicating the widespread dissemination of invasive candidiasis. This pain occurs when the Candida fungus, carried through the bloodstream, invades and establishes infection directly within the muscle tissue, a condition known as Candida myositis.

Unlike the generalized muscle soreness that might accompany a common viral illness like the flu, the myalgia associated with systemic candidiasis is often more severe, localized to specific muscle groups, and accompanied by exquisite tenderness upon palpation. Patients may describe the sensation as a deep, aching, or throbing pain that is constant and not relieved by rest or common pain relievers. This can be accompanied by significant muscle weakness, making movement difficult and painful.

The development of Candida myositis is a clear sign that the infection has become deeply invasive. The presence of the fungus within the muscle tissue triggers a localized, intense inflammatory response, leading to tissue damage, swelling, and pain. In some severe cases, this can lead to the formation of muscle abscesses, collections of pus within the muscle, which can be identified through imaging studies like an MRI or ultrasound. The diagnosis can be confirmed through a muscle biopsy, which would reveal the presence of yeast and hyphal forms of Candida amid inflamed muscle fibers.

The onset of severe, unexplained muscle pain and tenderness in a patient at risk for invasive candidiasis is a critical symptom. It not only points toward a systemic fungal infection but also highlights the extent of its spread, underscoring the urgency for aggressive antifungal therapy to eradicate the pathogen from these deep-seated tissue sites and prevent further damage.

Abdominal Pain

Abdominal pain is a concerning symptom of invasive candidiasis that typically signals the infection has spread from the bloodstream to one or more internal organs within the abdominal cavity. When Candida disseminates, it commonly seeds organs that are highly perfused with blood, such as the liver, spleen, and kidneys.

The presence of the fungus in these organs triggers inflammation (hepatitis, splenitis, nephritis) and can lead to the formation of multiple small abscesses. This condition is often referred to as hepatosplenic candidiasis or chronic disseminated candidiasis. The pain associated with this organ involvement can vary in character and location depending on which organs are affected. For example, infection in the liver or spleen may cause pain in the upper right or upper left quadrant of the abdomen, respectively. Kidney involvement can lead to flank pain that may radiate towards the groin.

The pain may be described as a dull, constant ache or, if an abscess is large or near the surface of the organ, a sharper, more localized pain. It can be accompanied by other signs of organ dysfunction, such as jaundice (yellowing of the skin and eyes) if the liver is severely affected, or changes in urinary output if the kidneys are involved. Fever and malaise are almost always present.

Diagnosing abdominal organ involvement requires imaging studies like an ultrasound, CT scan, or MRI, which can reveal the characteristic “bull’s-eye” or “wheel-within-a-wheel” lesions in the liver and spleen that are highly suggestive of fungal abscesses. The development of new or worsening abdominal pain in a high-risk individual should never be ignored, as it indicates a severe and deeply invasive form of the disease that requires prolonged and intensive antifungal treatment to resolve.

Vision Changes, such as Blurriness or Eye Pain

The development of vision changes, including blurred vision, floating spots, eye pain, or light sensitivity (photophobia), is a critical symptom of invasive candidiasis that points to a specific and dangerous complication called Candida endophthalmitis. This condition occurs when the Candida fungus, circulating in the bloodstream, crosses the blood-retina barrier and seeds the interior structures of the eye, particularly the retina and the vitreous humor (the gel-like substance that fills the eyeball).

The infection establishes itself inside the eye, leading to inflammation of these delicate tissues. Early on, patients may notice an increase in floaters, small specks or clouds moving in their field of vision, which are actually clumps of inflammatory cells and fungal organisms floating in the vitreous. As the infection progresses, the inflammation can cause the vitreous to become cloudy and can damage the retina, leading to blurred or decreased vision.

Candida endophthalmitis is a medical emergency because if it is not diagnosed and treated promptly, it can lead to irreversible damage to the retina and optic nerve, resulting in permanent vision loss or complete blindness in the affected eye. The diagnosis is typically made by an ophthalmologist who performs a dilated fundus examination, allowing them to look at the back of the eye.

They may see characteristic white, fluffy retinal or vitreal lesions, which are hallmarks of the condition. Treatment requires not only systemic intravenous antifungal medication to control the body-wide infection but often also involves direct injection of antifungal drugs into the eye (intravitreal injection) or a surgical procedure called a vitrectomy to remove the infected vitreous gel. The onset of any new visual symptoms in a patient with known or suspected candidemia must be evaluated by an ophthalmologist immediately.

Neurological Symptoms like Confusion or Difficulty Concentrating

The emergence of neurological symptoms, such as acute confusion, delirium, memory problems, or difficulty concentrating, represents one of the most severe and life-threatening manifestations of invasive candidiasis. These symptoms indicate that the infection has breached the highly protective blood-brain barrier and has invaded the central nervous system (CNS).

When Candida spreads to the brain and its surrounding structures, it can cause several devastating conditions, including meningitis (inflammation of the membranes covering the brain and spinal cord), meningoencephalitis (inflammation of both the membranes and the brain tissue itself), or the formation of brain abscesses (localized collections of pus within the brain tissue). The presence of the fungus in the CNS triggers an intense inflammatory response, leading to swelling, increased intracranial pressure, and disruption of normal brain function.

The clinical presentation can be varied and may include severe headaches, stiff neck, seizures, focal neurological deficits (such as weakness in one part of the body), and significant changes in mental status. A patient may become lethargic, disoriented, agitated, or even comatose.

Diagnosing CNS candidiasis is challenging and requires a high degree of clinical suspicion. It typically involves neuroimaging, such as a CT scan or MRI of the brain, to look for abscesses or signs of inflammation. A lumbar puncture (spinal tap) is often necessary to obtain a sample of cerebrospinal fluid (CSF) for analysis.

The presence of Candida in the CSF confirms the diagnosis. CNS involvement in invasive candidiasis carries an extremely high mortality rate and, even in survivors, can lead to long-term, permanent neurological damage. It is a sign of advanced, uncontrolled disease that requires immediate, aggressive, and prolonged treatment with antifungal agents that can effectively penetrate the blood-brain barrier.

What Exactly Is a Systemic Yeast Infection (Invasive Candidiasis)?

What Defines Invasive Candidiasis?

Invasive candidiasis is formally defined as a fungal infection that occurs when Candida, a type of yeast that is a normal inhabitant of the human skin, mouth, and gastrointestinal tract, breaches the body’s natural barriers and enters the bloodstream. This specific event of having Candida in the blood is called candidemia, and it is the most common form of invasive candidiasis. From the bloodstream, the yeast can travel throughout the body and “seed” or establish secondary infections in deep-seated organs. This dissemination can lead to severe and life-threatening complications as the fungus proliferates in vital tissues.

The potential targets for this dissemination are widespread and include the heart (endocarditis), brain (meningitis, brain abscesses), eyes (endophthalmitis), kidneys, liver, spleen, bones (osteomyelitis), and joints (septic arthritis). Unlike superficial Candida infections, such as oral thrush or vaginal yeast infections, which remain localized to mucosal surfaces and are rarely dangerous in healthy individuals, invasive candidiasis is a systemic disease with a high mortality rate, often exceeding 40% even with treatment.

It is considered an opportunistic infection, meaning it primarily affects individuals whose immune systems are compromised or whose natural protective barriers have been breached, such as by an intravenous catheter or major surgery. The defining characteristic is the invasion of the fungus into sterile body sites, turning a typically harmless commensal organism into a deadly pathogen.

Is Invasive Candidiasis Contagious?

No, a systemic yeast infection (invasive candidiasis) is not contagious and cannot be spread from person to person. This is a critical distinction to understand. The Candida yeast that causes the infection is not typically acquired from an external source or another infected individual. Instead, invasive candidiasis is almost always an endogenous infection, meaning it arises from the overgrowth of the Candida yeast that is already living harmlessly as part of a person’s own microbiome on their skin, in their mouth, or within their gastrointestinal tract. This yeast is present in the majority of healthy people and causes no problems under normal circumstances.

The infection develops when specific conditions allow this normally benign yeast to become pathogenic and invade the body. The primary prerequisite is a significant breakdown in the host’s defenses. This can happen in several ways. A severely weakened immune system (e.g., due to chemotherapy, immunosuppressant drugs, or advanced HIV) can no longer keep the yeast population in check.

The widespread use of broad-spectrum antibiotics can kill off beneficial bacteria in the gut, allowing Candida to overgrow and potentially translocate across the gut wall into the bloodstream. Physical breaches in the skin or mucosal barriers, such as central venous catheters, surgical wounds, or severe burns, can provide a direct entry point for the yeast to access the bloodstream. Therefore, invasive candidiasis is an opportunistic infection that develops internally within a susceptible individual; it is not a communicable disease that can be passed through casual contact, airborne droplets, or other common modes of transmission.

Invasive Candidiasis Diagnosis

The definitive method for diagnosing invasive candidiasis is a blood culture. This diagnostic test involves drawing a sample of the patient’s blood and placing it in a special medium that encourages the growth of microorganisms. If Candida species are present in the blood (candidemia), they will multiply in the culture over several days, allowing for identification.

However, because blood cultures can be slow and are not always positive even when an infection is present, clinicians often rely on other methods for a faster diagnosis, especially in critically ill patients. One such method is the (1,3)-Beta-D-glucan (BDG) test, which detects a component of the fungal cell wall in the blood. Another rapid diagnostic tool is the T2Candida Panel, which uses magnetic resonance technology to detect Candida DNA directly from a blood sample in just a few hours.

In cases where the infection is suspected to have spread to specific organs, doctors may perform a tissue biopsy. This involves taking a small sample of tissue from an affected organ, such as the liver, kidney, or lung, and examining it under a microscope for evidence of yeast. This approach provides direct proof of a deep-seated infection and helps guide treatment.

Invasive Candidiasis vs. Oral Thrush or a Vaginal Yeast Infection

The primary distinction between invasive candidiasis and more common yeast infections lies in their location, scope, and severity. Oral thrush and vaginal yeast infections are localized and superficial, whereas invasive candidiasis is a systemic, life-threatening condition. Understanding these differences is vital for appropriate medical response.

Localized infections (oral thrush/vaginal yeast infection) are confined to the mucous membranes of a specific area, such as the mouth (oropharyngeal candidiasis) or vagina (vulvovaginal candidiasis). The Candida yeast overgrows on the surface but does not penetrate the bloodstream or internal organs. Symptoms include white patches, soreness, and discharge. While uncomfortable, these infections are generally not dangerous for individuals with healthy immune systems and can be effectively treated with topical creams or oral antifungal pills.

Systemic infection (invasive candidiasis) is a severe infection where Candida enters the bloodstream, a condition known as candidemia. From the bloodstream, the yeast can travel throughout the body and establish deep-seated infections in vital organs like the heart, brain, eyes, bones, and kidneys. It is a medical emergency that occurs almost exclusively in hospitalized or severely immunocompromised patients and requires aggressive treatment with intravenous antifungal medications.

Potential Long-Term Complications of Invasive Candidiasis

If not diagnosed and treated rapidly, invasive candidiasis can lead to devastating and permanent complications affecting multiple organ systems. The infection’s ability to spread throughout the body means the damage can be widespread and severe, often resulting in long-term health issues or death. One of the most immediate and dangerous outcomes is septic shock, a life-threatening condition where the body’s overwhelming response to the infection causes dangerously low blood pressure and widespread inflammation, leading to organ failure.

Specific organs are particularly vulnerable to long-term damage. The kidneys and liver are common targets. The infection can cause acute kidney injury, potentially requiring dialysis, or lead to liver abscesses and impaired function.

When Candida infects the inner lining of the heart chambers and valves, it causes endocarditis. This can destroy heart valves, leading to heart failure and often requiring complex open-heart surgery to replace the damaged tissue.

If the yeast travels to the eyes, it can cause endophthalmitis, an infection inside the eyeball. This condition can lead to inflammation, retinal damage, and, if not treated aggressively, permanent vision loss or complete blindness.

Additionally, the infection can settle in the bones (osteomyelitis) or joints (septic arthritis), causing chronic pain, destruction of bone tissue, and long-term mobility issues.

Who Is in the High-Risk Group for Developing this Infection?

Invasive candidiasis is not a condition that affects the general, healthy population; it primarily targets individuals whose bodies are already under significant medical stress or whose immune systems are compromised. Identifying these high-risk groups is critical for prevention and early diagnosis. The most vulnerable populations are typically found within hospital settings, particularly in intensive care.

Intensive Care Unit (ICU) patients are at the highest risk due to a combination of factors, including a weakened state, the presence of multiple medical devices, and prolonged antibiotic use that disrupts the body’s natural microbiome.

Besides, individuals with Central Venous Catheters (CVCs), often called central lines, are inserted into large veins to administer medication or fluids. They create a direct pathway for Candida on the skin to enter the bloodstream, making them a major risk factor for candidemia.

Individuals who have undergone significant surgical procedures, especially abdominal surgery, are more susceptible. The surgery itself can be a source of entry for yeast, and the recovery process places immense stress on the body.

Specially, severely Immunocompromised patients includes several groups whose immune defenses are critically low. Examples include organ transplant recipients taking immunosuppressive drugs to prevent rejection, cancer patients undergoing chemotherapy that destroys white blood cells, and individuals with neutropenia (an abnormally low count of neutrophils, a key type of white blood cell).

FAQs

1. How common is invasive candidiasis?

While localized yeast infections are incredibly common, invasive candidiasis is relatively rare but maintains a dangerous presence in hospital environments. According to the Centers for Disease Control and Prevention (CDC), it is one of the most widespread healthcare-associated bloodstream infections in the United States, causing an estimated 46,000 cases annually. It primarily targets hospitalized individuals, particularly those requiring intensive care.

2. How long does it take to get invasive candidiasis?

There is no fixed timeline, but it typically develops after a prolonged hospital stay. Clinical data shows that patients who contract a systemic Candida infection in an intensive care unit (ICU) have usually been admitted for a mean duration of roughly 10 to 14 days. This delay occurs because the fungus requires time to heavily colonize body surfaces, take advantage of weakened immunity, and finally breach tissue barriers via medical devices like IV lines.

3. What can cause invasive candidiasis?

Invasive candidiasis is caused when Candida yeast, which normally lives harmlessly on your skin and inside your gut, manages to enter the deep bloodstream. The primary triggers include prolonged use of broad-spectrum antibiotics (which wipe out the good bacteria that keep yeast in check), the use of central venous catheters or indwelling medical tubes that provide a physical highway for fungi to enter the body, recent major abdominal surgery, kidney failure requiring dialysis, or a heavily compromised immune system.

4. Can invasive Candida be cured?

Yes, invasive candidiasis can be cured, but the medical treatment is intense and demanding. Eradication requires the immediate physical removal of the source, such as pulling out any contaminated IV lines or catheters, coupled with aggressive intravenous (IV) antifungal medications. Doctors typically use specialized classes of antifungals called echinocandins as the first line of defense, closely monitoring the patient to clear the fungus from the blood entirely.

5. How do you know if you have an invasive fungal infection?

Determining if you have an invasive fungal infection is notoriously difficult because its symptoms mimic those of severe bacterial infections. The primary indicator is a high fever and violent chills that completely fail to respond to standard, heavy-duty antibiotics. Doctors must perform specialized blood cultures, or non-culture molecular tests like T2Candida and Beta-D-Glucan assays, to definitively spot the hidden fungal genetic material in your system.

6. What is the prognosis for invasive candidiasis?

The prognosis for invasive candidiasis remains highly guarded and serious. Because this infection primarily strikes individuals who are already critically ill or medically vulnerable, it carries a severe 30% to 40% all-cause mortality rate within 30 days of infection. For survivors, the road to recovery can be incredibly long, and complications depend heavily on where the fungus migrated, for instance, if it takes root in the eyes, it can cause partial or total blindness.

7. Is invasive candidiasis an emergency?

Yes, without question. Invasive candidiasis is a life-threatening medical emergency. Once the Candida fungus gains unrestricted access to your bloodstream, it moves incredibly fast. If intravenous antifungal treatment is delayed by even a single day, the risk of the infection causing widespread septic shock, irreversible organ failure, and death increases exponentially.

Conclusion

Invasive candidiasis serves as a sobering reminder that the microscopic organisms living harmlessly on our skin can transform into deadly adversaries under the right clinical conditions. Far removed from the mild, localized yeast overgrowths most people encounter, a systemic Candida infection is a high-stakes medical emergency that aggressively attacks the bloodstream and vital internal organs.

Because its 8 key symptoms so easily mimic common bacterial illnesses, maintaining a high index of suspicion, especially for those who are hospitalized or immunologically compromised, is absolutely paramount. Early identification through advanced diagnostic testing and the rapid deployment of targeted intravenous antifungals are the ultimate deciding factors between recovery and catastrophic organ damage.

By understanding the gravity of this systemic invader, patients, families, and healthcare providers can act decisively at the first sign of a persistent, antibiotic-resistant fever, ensuring this silent threat is stopped before it can claim another life.

References

• CDC – Clinical Overview of Invasive Candidiasis
• WHO – Candidiasis (yeast infection)
• National Library of Medicine – Diagnosis and Treatment of Invasive Candidiasis
• American Thoracic Society – Candidemia (Blood Infection) and Other Candida Infections
• CDC – Candidiasis Basics
• ICDM – Candida Infections: Clinical Features, Diagnosis and Treatment
• CDC – Testing and Diagnosis for Candidiasis
• UC Regents – Yeast Infection (Candidiasis)
• National Library of Medicine – Diagnosing Invasive Candidiasis
• The Oral Cancer Foundation – Candida Infection